The Role and Expression of Angiogenesis-Related MiRNAs in Gastric Cancer

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2021 Mar 6

PMID 33673057

Citations 10

Authors

Martina Giuppi

Anna La Salvia

Jessica Evangelista

Michele Ghidini

Affiliations

Soon will be listed here.

Abstract

Gastric cancer (GC) is the fifth most frequently diagnosed malignant tumor and the third highest cause of cancer mortality worldwide. For advanced GC, many novel drugs and combinations have been tested, but results are still disappointing, and the disease is incurable in the majority of cases. In this regard, it is critical to investigate the molecular mechanisms underlying GC development. Angiogenesis is one of the hallmarks of cancer with a fundamental role in GC growth and progression. Ramucirumab, a monoclonal antibody that binds to vascular endothelial growth factor-2 (VEGFR-2), is approved in the treatment of advanced and pretreated GC. However, no predictive biomarkers for ramucirumab have been identified so far. Micro RNAs (miRNAs) are a class of evolutionarily-conserved single-stranded non-coding RNAs that play an important role (via post-transcriptional regulation) in essentially all biologic processes, such as cell proliferation, differentiation, apoptosis, survival, invasion, and migration. In our review, we aimed to analyze the available data on the role of angiogenesis-related miRNAs in GC.

Citing Articles

Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab-Paclitaxel Therapy Outcomes in Advanced Gastric Cancer.

Piccinno E, Schirizzi A, Scalavino V, De Leonardis G, Donghia R, Fantasia A Int J Mol Sci. 2025; 25(24.

PMID: 39769259 PMC: 11677161. DOI: 10.3390/ijms252413498.

High microvessel and lymphatic vessel density predict poor prognosis in patients with esophageal squamous cell carcinoma.

Qi L, Xie Y, Wang W, Liu J, Yang K, Chen K PeerJ. 2024; 12:e18080.

PMID: 39351370 PMC: 11441385. DOI: 10.7717/peerj.18080.

Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity.

Bhattacharjee A, Sahoo O, Sarkar A, Bhattacharya S, Chowdhury R, Kar S Infection. 2024; 52(2):345-384.

PMID: 38270780 DOI: 10.1007/s15010-023-02159-9.

Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance.

Zhang C, Qin C, Dewanjee S, Bhattacharya H, Chakraborty P, Jha N Mol Cancer. 2024; 23(1):18.

PMID: 38243280 PMC: 10797874. DOI: 10.1186/s12943-024-01932-0.

Long non-coding RNA NEAT1 promotes angiogenesis in hepatoma carcinoma via the miR-125a-5p/VEGF pathway.

Guo J, Yuan Q, Fang Y, Liao J, Zhang Z Open Life Sci. 2022; 17(1):1229-1239.

PMID: 36213383 PMC: 9490857. DOI: 10.1515/biol-2022-0498.

References

Chalhoub N, Baker S . PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2008; 4:127-50. PMC: 2710138. DOI: 10.1146/annurev.pathol.4.110807.092311. View

Lathia J, Heddleston J, Venere M, Rich J . Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell. 2011; 8(5):482-5. PMC: 3494093. DOI: 10.1016/j.stem.2011.04.013. View

Trusolino L, Comoglio P . Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer. 2002; 2(4):289-300. DOI: 10.1038/nrc779. View

Cuzziol C, Castanhole-Nunes M, Pavarino E, Goloni-Bertollo E . MicroRNAs as regulators of VEGFA and NFE2L2 in cancer. Gene. 2020; 759:144994. DOI: 10.1016/j.gene.2020.144994. View

Nie H, Xie X, Zhang D, Zhou Y, Li B, Li F . Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer. Nanoscale. 2019; 12(2):877-887. DOI: 10.1039/c9nr09011h. View

Holmes D, Zachary I . The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005; 6(2):209. PMC: 551528. DOI: 10.1186/gb-2005-6-2-209. View

Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y . Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis. Mol Biol Rep. 2012; 39(10):9473-84. DOI: 10.1007/s11033-012-1812-8. View

Wang Y, Wang L, Chen C, Chu X . New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer. 2018; 17(1):22. PMC: 5804051. DOI: 10.1186/s12943-018-0766-4. View

Yan J, Zhang Y, Liao J, Ke K, Chang Y, Li P . MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget. 2015; 6(30):29527-42. PMC: 4745744. DOI: 10.18632/oncotarget.5012. View

10.

Lee S, Rouhi P, Jensen L, Zhang D, Ji H, Hauptmann G . Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci U S A. 2009; 106(46):19485-90. PMC: 2780785. DOI: 10.1073/pnas.0909228106. View

11.

Li J, Qin S, Xu J, Xiong J, Wu C, Bai Y . Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. J Clin Oncol. 2016; 34(13):1448-54. DOI: 10.1200/JCO.2015.63.5995. View

12.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

13.

Forma A, Tyczynska M, Kedzierawski P, Gietka K, Sitarz M . Gastric carcinogenesis: a comprehensive review of the angiogenic pathways. Clin J Gastroenterol. 2020; 14(1):14-25. PMC: 7886717. DOI: 10.1007/s12328-020-01295-1. View

14.

Wang R, Zhao N, Li S, Fang J, Chen M, Yang J . MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology. 2013; 58(2):642-53. DOI: 10.1002/hep.26373. View

15.

Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks S, Marrero M . VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J. 2003; 17(11):1562-4. DOI: 10.1096/fj.02-1084fje. View

16.

Refolo M, Lotesoriere C, Lolli I, Messa C, DAlessandro R . Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell lines. Sci Rep. 2020; 10(1):7162. PMC: 7188894. DOI: 10.1038/s41598-020-64195-x. View

17.

Hansen T, Carlsen A, Heegaard N, Sorensen F, Jakobsen A . Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer. Br J Cancer. 2015; 112(4):624-9. PMC: 4333496. DOI: 10.1038/bjc.2014.652. View

18.

Organ S, Tsao M . An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011; 3(1 Suppl):S7-S19. PMC: 3225017. DOI: 10.1177/1758834011422556. View

19.

Winter J, Diederichs S . MicroRNA biogenesis and cancer. Methods Mol Biol. 2010; 676:3-22. DOI: 10.1007/978-1-60761-863-8_1. View

20.

Switlik W, Karbownik M, Suwalski M, Kozak J, Szemraj J . Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study. Genet Test Mol Biomarkers. 2019; 23(5):353-358. DOI: 10.1089/gtmb.2018.0275. View